BioTrends Research Group Releases Non-Small-Cell Lung Cancer Report Findings
One hundred and five US-based medical oncologists were surveyed about their current and expected treatment patterns in one of the largest oncology indications.
Read MoreOne hundred and five US-based medical oncologists were surveyed about their current and expected treatment patterns in one of the largest oncology indications.
Read MoreSequenom’s participation in the PHCS and MultiPlan networks will now include its Center for Molecular Medicine’s MaterniT21 PLUS laboratory-developed test.
Read MoreExpress Diagnostics offers a full range of DOT-approved on-site tests.
Read MoreThe Dark Report offers a chance to download its recently published free white paper “Data Mining and Dashboarding Within Your Clinical Laboratory and Pathology Environment.”
Read MoreThe VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer patients treated with the combination therapy bevacizumab plus erlotinib.
Read More